Tetrabenazine

solute carrier family 18 (vesicular monoamine), member 2 ; Mus musculus







11 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 29408363 Dopamine depletion shifts behavior from activity based reinforcers to more sedentary ones and adenosine receptor antagonism reverses that shift: Relation to ventral striatum DARPP32 phosphorylation patterns. 2018 Aug 2
2 25762295 Pancreatic Differentiation from Murine Embryonic Stem Cells. 2016 3
3 24002822 Histamine synthesis is required for granule maturation in murine mast cells. 2014 Jan 1
4 24316738 VMAT2 identified as a regulator of late-stage β-cell differentiation. 2014 Feb 4
5 23867769 The vesicular monoamine transporter (VMAT-2) inhibitor tetrabenazine induces tremulous jaw movements in rodents: implications for pharmacological models of parkinsonian tremor. 2013 Oct 10 1
6 18248620 Characterization of the striatal dopaminergic neurotransmission in MEN2B mice with elevated cerebral tissue dopamine. 2008 Jun 1
7 16934687 Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. 2006 Aug 1
8 11489261 Interactions of 1-methyl-4-phenylpyridinium and other compounds with P-glycoprotein: relevance to toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. 2001 Aug 10 1
9 10415365 Ketanserin and tetrabenazine abolish aggression in mice lacking monoamine oxidase A. 1999 Jul 24 2
10 9080483 Time-dependent recovery of in vivo binding sites after drug dosing: a method for radiotracer evaluation. 1997 Jan 1
11 3380081 Ketanserin binds to the monoamine transporter of chromaffin granules and of synaptic vesicles. 1988 Jun 2